Cargando…
Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
PURPOSE: Continuous reductions in trabecular meshwork (TM) cellularity inhibit aqueous humor (AH) outflow, which is the main cause of primary open-angle glaucoma. Rho-associated protein kinase inhibitor (ROCKi) targets the TM to reduce intraocular pressure (IOP) and increase AH outflow facility. How...
Autores principales: | Chen, Wenshi, Yang, Xuejiao, Fang, Jingwang, Zhang, Yuqing, Zhu, Wei, Yang, Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090161/ https://www.ncbi.nlm.nih.gov/pubmed/32256367 http://dx.doi.org/10.3389/fphar.2020.00302 |
Ejemplares similares
-
Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork
por: Okamoto, Mizu, et al.
Publicado: (2020) -
Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells
por: Ramachandran, C., et al.
Publicado: (2011) -
Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
por: Zhu, Xiaolu, et al.
Publicado: (2020) -
Cationic Mechanosensitive Channels Mediate Trabecular Meshwork Responses to Cyclic Mechanical Stretch
por: Chen, Susu, et al.
Publicado: (2022) -
Regulatory Roles of Anoctamin-6 in Human Trabecular Meshwork Cells
por: Banerjee, Juni, et al.
Publicado: (2017)